News Conference News AHA 2024 Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF Shelley Wood November 18, 2024
News Conference News AHA 2024 Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients Shelley Wood November 16, 2024
News Conference News TCT 2024 Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI Michael O'Riordan November 06, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Daily News Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows L.A. McKeown October 09, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Conference News ESC 2024 Trial Challenges Continuation of Oral Anticoagulants During TAVI Todd Neale August 31, 2024
Presentation ESC 2024 Continuation versus Interruption of Oral Anticoagulation during TAVI Presenter: Dirk-Jan van Ginkel August 31, 2024
News Daily News Good News for CV Recovery After COVID-19 Vaccine Myocarditis Yael L. Maxwell August 29, 2024
News Daily News AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients Michael O'Riordan August 26, 2024
News Daily News Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis Todd Neale July 12, 2024
News Daily News Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF Michael O'Riordan July 09, 2024
News Daily News Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA L.A. McKeown July 02, 2024
News Conference News NY Valves 2024 Long-term Mortality After TAVI Lower With DOACs vs VKAs Todd Neale June 06, 2024
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024